December 31, 2021
CBD Global Sciences, Inc. is pleased to announce the completion of its previously announced (August 12, 2021) debt restructuring involving the retirement of over CDN$9 million in outstanding debt through the issuance of 8,908,876 Common Shares at an issue price of $0.1575 per share and 318,688 Series A preferred shares […]